The Board of Directors of Bristol-Myers
Squibb Company (NYSE:BMY) today declared a quarterly dividend of
forty cents ($0.40) per share on the $.10 par value Common Stock of the
corporation. The next quarterly dividend will be payable on May 1, 2018,
to stockholders of record at the close of business on April 6, 2018.
The directors also declared a quarterly dividend of fifty cents ($0.50)
per share on the $2.00 Convertible Preferred Stock of the corporation,
payable June 1, 2018 to stockholders of record at the close of business
on May 8, 2018.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information, please
visit www.bms.com
or follow us on Twitter at http://twitter.com/bmsnews.
Bristol-Myers SquibbMedia:Ken Dominski, 609-252-5251 ken.dominski@bms.com orLisa McCormick Lavery, 609-252-7602 lisa.mccormicklavery@bms.com or Investors: Tim Power, 609-252-7509 timothy.power@bms.com orBill Szablewski, 609-252-5894 william.szablewski@bms.com